Abstract
A Model for Predicting Effect of Treatment on Progression-Free Survival Using Minimal Residual Disease As a Surrogate Endpoint in Chronic Lymphocytic Leukemia
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have